Загрузка...

The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update

Current research indicates that the next silent epidemic will be linked to chronic liver diseases, specifically non-alcoholic fatty liver disease (NAFLD), which was renamed as metabolic-associated fatty liver disease (MAFLD) in 2020. Globally, MAFLD mortality is on the rise. The etiology of MAFLD is...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pharmaceuticals (Basel)
Главные авторы: Abou Assi, Reem, Abdulbaqi, Ibrahim M., Siok Yee, Chan
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8001129/
https://ncbi.nlm.nih.gov/pubmed/33806527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030215
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!